{"nct_id":"NCT05276297","title":"A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-06","start_date":"2022-03-22","start_date_type":"ACTUAL","primary_completion_date":"2025-08-11","primary_completion_date_type":"ESTIMATED","completion_date":"2025-08-11","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["GSK"]}